{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:15:47Z","timestamp":1790356547161,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA229102"],"award-info":[{"award-number":["T32 CA229102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA229102"],"award-info":[{"award-number":["T32 CA229102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA229102"],"award-info":[{"award-number":["T32 CA229102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM008361"],"award-info":[{"award-number":["5T32GM008361"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA091078"],"award-info":[{"award-number":["T32 CA091078"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA013148"],"award-info":[{"award-number":["P30 CA013148"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003287","name":"Rally Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope On Wheels","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018476","name":"Vince Lombardi Cancer Foundation","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100018476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015633","name":"Kaul Pediatric Research Institute","doi-asserted-by":"publisher","award":["na"],"award-info":[{"award-number":["na"]}],"id":[{"id":"10.13039\/100015633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10585-022-10186-3","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T05:02:23Z","timestamp":1667192543000},"page":"899-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4"],"prefix":"10.1007","volume":"39","author":[{"given":"Raoud","family":"Marayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Julson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura V.","family":"Bownes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin H.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Stafman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andee M.","family":"Beierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooper R.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Hutchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita B.","family":"Hjelmeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mroczek-Musulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Beierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"issue":"1","key":"10186_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","volume":"39","author":"J Feng","year":"2019","unstructured":"Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K (2019) Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond) 39(1):62","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10186_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","volume":"26","author":"RL Meyers","year":"2014","unstructured":"Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC (2014) Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr 26(1):29\u201336","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"10186_CR3","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D","volume":"89","author":"G Perilongo","year":"2000","unstructured":"Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW et al (2000) Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 89(8):1845\u20131853","journal-title":"Cancer"},{"issue":"32","key":"10186_CR4","doi-asserted-by":"publisher","first-page":"22665","DOI":"10.18632\/oncotarget.25205","volume":"9","author":"LL Stafman","year":"2018","unstructured":"Stafman LL, Mruthyunjayappa S, Waters AM, Garner EF, Aye JM, Stewart JE et al (2018) Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget 9(32):22665\u201322679","journal-title":"Oncotarget"},{"key":"10186_CR5","doi-asserted-by":"crossref","unstructured":"Maryati R, Julson JR, Bownes LV, Quinn CH, Hutchins SC, Williams AP, Markert HR, Beierle AM, Stewart JE, Hjelmeland AB, Mroczek-Musulman E, Beierle EA (2022) Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem-cell like phenotype. J of Pediatr Surg. ; in press","DOI":"10.1016\/j.jpedsurg.2022.01.063"},{"key":"10186_CR6","doi-asserted-by":"crossref","unstructured":"Marayati R, Stafman LL, Williams AP, Bownes LV, Quinn CH, Markert HR et al (2021) CRISPR\/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.Cancer Gene Ther.","DOI":"10.1038\/s41417-021-00334-4"},{"issue":"4","key":"10186_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00432-007-0310-1","volume":"134","author":"HC Zheng","year":"2008","unstructured":"Zheng HC, Tsuneyama K, Takahashi H, Miwa S, Sugiyama T, Popivanova BK et al (2008) Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression. J Cancer Res Clin Oncol 134(4):481\u2013488","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10186_CR8","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.7314\/APJCP.2015.16.8.3325","volume":"16","author":"H Zhuang","year":"2015","unstructured":"Zhuang H, Zhao MY, Hei KW, Yang BC, Sun L, Du X et al (2015) Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells. Asian Pac J Cancer Prev 16(8):3325\u20133331","journal-title":"Asian Pac J Cancer Prev"},{"key":"10186_CR9","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.12659\/MSM.898223","volume":"22","author":"Y Qu","year":"2016","unstructured":"Qu Y, Zhang C, Du E, Wang A, Yang Y, Guo J et al (2016) Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer. Med Sci Monit 22:4254\u20134260","journal-title":"Med Sci Monit"},{"issue":"6","key":"10186_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jpedsurg.2019.02.029","volume":"54","author":"LL Stafman","year":"2019","unstructured":"Stafman LL, Waldrop MG, Williams AP, Aye JM, Stewart JE, Mroczek-Musulman E et al (2019) The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival. J Pediatr Surg 54(6):1206\u20131213","journal-title":"J Pediatr Surg"},{"issue":"5\u20136","key":"10186_CR11","first-page":"247","volume":"22","author":"Q Guo","year":"2014","unstructured":"Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan QY et al (2014) CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer. Oncol Res 22(5\u20136):247\u2013258","journal-title":"Oncol Res"},{"issue":"6","key":"10186_CR12","doi-asserted-by":"publisher","first-page":"e0130340","DOI":"10.1371\/journal.pone.0130340","volume":"10","author":"NM Santio","year":"2015","unstructured":"Santio NM, Eerola SK, Paatero I, Yli-Kauhaluoma J, Anizon F, Moreau P et al (2015) Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts. PLoS ONE 10(6):e0130340","journal-title":"PLoS ONE"},{"issue":"7","key":"10186_CR13","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1111\/jcmm.13632","volume":"22","author":"E Bialopiotrowicz","year":"2018","unstructured":"Bialopiotrowicz E, Gorniak P, Noyszewska-Kania M, Pula B, Makuch-Lasica H, Nowak G et al (2018) Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration. J Cell Mol Med 22(7):3548\u20133559","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10186_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1593\/tlo.12505","volume":"6","author":"LA Gillory","year":"2013","unstructured":"Gillory LA, Stewart JE, Megison ML, Nabers HC, Mroczek-Musulman E, Beierle EA (2013) FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo. Transl Oncol 6(2):206\u2013215","journal-title":"Transl Oncol"},{"key":"10186_CR15","doi-asserted-by":"crossref","unstructured":"Chen Z, Ren X, Ren R, Wang Y, Shang J (2021) The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice.Stem Cell Research & Therapy. ; 12(1)","DOI":"10.1186\/s13287-021-02268-y"},{"issue":"1","key":"10186_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321","journal-title":"Bioinformatics"},{"issue":"3","key":"10186_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7(3):562\u2013578","journal-title":"Nat Protoc"},{"issue":"5","key":"10186_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511\u2013515","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10186_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30(4):523\u2013530","journal-title":"Bioinformatics"},{"key":"10186_CR20","doi-asserted-by":"crossref","unstructured":"Hiyama E, Ueda Y, Kurihara S, Kawashima K, Ikeda K, Morihara N, Fukazawa T, Kanawa M, Hiyama K (2019) Gene expression profiling in hepatoblastoma cases of the Japanese Study Group for Pediatric Liver Tumors-2 (JPLT-2) trial.Eur J Mol Cancer.","DOI":"10.31487\/j.EJMC.2018.01.003"},{"issue":"2","key":"10186_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sabat M, Abril- Fornaguera J et al (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73(2):328\u2013341","journal-title":"J Hepatol"},{"key":"10186_CR22","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365\u2013386","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10186_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abio.1999.4085","volume":"270","author":"J Winer","year":"1999","unstructured":"Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270(1):41\u201349","journal-title":"Anal Biochem"},{"issue":"3","key":"10186_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/JP9.0000000000000024","volume":"2","author":"L Tang","year":"2019","unstructured":"Tang L, Zhang H, Zhang B (2019) A note on error bars as a graphical representation of the variability of data in biomedical research: Choosing between standard deviation and standard error of the mean. J Pancreatol 2(3):69\u201371","journal-title":"J Pancreatol"},{"key":"10186_CR25","doi-asserted-by":"crossref","unstructured":"Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK et al The soft agar colony formation assay.J Vis Exp. 2014(92):e51998","DOI":"10.3791\/51998"},{"issue":"1\u20133","key":"10186_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","volume":"527","author":"S Hatse","year":"2002","unstructured":"Hatse S, Princen K, Bridger G, De Clercq E, Schols D (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527(1\u20133):255\u2013262","journal-title":"FEBS Lett"},{"issue":"1","key":"10186_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"12","key":"10186_CR28","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","volume":"79","author":"DR Welch","year":"2019","unstructured":"Welch DR, Hurst DR (2019) Defining the Hallmarks of Metastasis. Cancer Res 79(12):3011\u20133027","journal-title":"Cancer Res"},{"issue":"8","key":"10186_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563\u2013572","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"10186_CR30","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1128\/MCB.24.22.9726-9735.2004","volume":"24","author":"JA Nagle","year":"2004","unstructured":"Nagle JA, Ma Z, Byrne MA, White MF, Shaw LM (2004) Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 24(22):9726\u20139735","journal-title":"Mol Cell Biol"},{"issue":"26","key":"10186_CR31","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1038\/sj.onc.1207595","volume":"23","author":"SS Martin","year":"2004","unstructured":"Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY et al (2004) A cytoskeleton- based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene 23(26):4641\u20134645","journal-title":"Oncogene"},{"key":"10186_CR32","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.2147\/OTT.S245578","volume":"13","author":"H Luo","year":"2020","unstructured":"Luo H, Sun R, Zheng Y, Huang J, Wang F, Long D et al (2020) PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells. Onco Targets Ther 13:6897\u20136905","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10186_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/15384047.2017.1414756","volume":"19","author":"J Liu","year":"2018","unstructured":"Liu J, Qu X, Shao L, Hu Y, Yu X, Lan P et al (2018) Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation. Cancer Biol Ther 19(3):160\u2013168","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10186_CR34","first-page":"385","volume":"5","author":"OM Rashid","year":"2013","unstructured":"Rashid OM, Nagahashi M, Ramachandran S, Dumur CI, Schaum JC, Yamada A et al (2013) Is tail vein injection a relevant breast cancer lung metastasis model? J Thorac Dis 5(4):385\u2013392","journal-title":"J Thorac Dis"},{"key":"10186_CR35","first-page":"1347","volume":"6","author":"M Cojoc","year":"2013","unstructured":"Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A (2013) Emerging targets in cancer management: role of the CXCL12\/CXCR4 axis. Onco Targets Ther 6:1347\u20131361","journal-title":"Onco Targets Ther"},{"issue":"7","key":"10186_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","volume":"4","author":"F Balkwill","year":"2004","unstructured":"Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4(7):540\u2013550","journal-title":"Nat Rev Cancer"},{"issue":"6685","key":"10186_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/31269","volume":"393","author":"YR Zou","year":"1998","unstructured":"Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393(6685):595\u2013599","journal-title":"Nature"},{"issue":"1","key":"10186_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/leu.2008.299","volume":"23","author":"JA Burger","year":"2009","unstructured":"Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23(1):43\u201352","journal-title":"Leukemia"},{"issue":"3","key":"10186_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jcb.10522","volume":"89","author":"YX Sun","year":"2003","unstructured":"Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA et al (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89(3):462\u2013473","journal-title":"J Cell Biochem"},{"issue":"3","key":"10186_CR40","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acs.jproteome.9b00821","volume":"19","author":"Y Dang","year":"2020","unstructured":"Dang Y, Jiang N, Wang H, Chen X, Gao Y, Zhang X et al (2020) Proto-Oncogene Serine\/Threonine Kinase PIM3 Promotes Cell Migration via Modulating Rho GTPase Signaling. J Proteome Res 19(3):1298\u20131309","journal-title":"J Proteome Res"},{"issue":"6","key":"10186_CR41","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3892\/or.2014.3158","volume":"31","author":"B Liu","year":"2014","unstructured":"Liu B, Wang Z, Li HY, Zhang B, Ping B, Li YY (2014) Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis. Oncol Rep 31(6):2625\u20132634","journal-title":"Oncol Rep"},{"issue":"5","key":"10186_CR42","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1158\/1535-7163.MCT-13-0575-T","volume":"13","author":"S Decker","year":"2014","unstructured":"Decker S, Finter J, Forde AJ, Kissel S, Schwaller J, Mack TS et al (2014) PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2\/3) and CXCR4- mediated microenvironmental interactions (PIM1). Mol Cancer Ther 13(5):1231\u20131245","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"10186_CR43","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/CBI20100744","volume":"35","author":"Q Wang","year":"2011","unstructured":"Wang Q, Diao X, Sun J, Chen Z (2011) Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line. Cell Biol Int 35(9):897\u2013904","journal-title":"Cell Biol Int"},{"issue":"4","key":"10186_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1705908","volume":"41","author":"G Calandra","year":"2008","unstructured":"Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, Badel K et al (2008) AMD3100 plus G-CSF can successfully mobilize CD34 + cells from non-Hodgkin\u2019s lymphoma, Hodgkin\u2019s disease and multiple myeloma patients previously failing mobilization with chemotherapy and\/or cytokine treatment: compassionate use data. Bone Marrow Transplant 41(4):331\u2013338","journal-title":"Bone Marrow Transplant"},{"key":"10186_CR45","doi-asserted-by":"crossref","unstructured":"Hira VVV, Van Noorden CJF, Molenaar RJ (2020) CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma? Biology (Basel). ; 9(2)","DOI":"10.3390\/biology9020031"},{"issue":"9","key":"10186_CR46","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1634\/stemcells.2007-0161","volume":"25","author":"M Abraham","year":"2007","unstructured":"Abraham M, Biyder K, Begin M, Wald H, Weiss ID, Galun E et al (2007) Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F- benzoyl-TN14003. Stem Cells 25(9):2158\u20132166","journal-title":"Stem Cells"},{"issue":"22","key":"10186_CR47","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-16-2919","volume":"23","author":"M Abraham","year":"2017","unstructured":"Abraham M, Pereg Y, Bulvik B, Klein S, Mishalian I, Wald H et al (2017) Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34(+) Cells in Healthy Volunteers. Clin Cancer Res 23(22):6790\u20136801","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10186_CR48","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.18632\/oncotarget.2407","volume":"5","author":"EA Sison","year":"2014","unstructured":"Sison EA, Magoon D, Li L, Annesley CE, Rau RE, Small D et al (2014) Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. Oncotarget 5(19):8947\u20138958","journal-title":"Oncotarget"},{"key":"10186_CR49","doi-asserted-by":"crossref","unstructured":"Grundler R, Brault L, Gasser C, Bullock AN, Dechow T, WoetzelS et al Dissection of PIM serine\/threonine kinases in FLT3-ITD\u2013induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4\u2013mediated homing and migration.J Exp Med 2009; 206:1957\u201370","DOI":"10.1084\/jem.20082074"},{"issue":"11","key":"10186_CR50","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41416-018-0082-1","volume":"118","author":"J Cortes","year":"2018","unstructured":"Cortes J, Tamura K, DeAngelo DJ, de Bono J, Lorente D, Minden M et al (2018) Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. Br J Cancer 118(11):1425\u20131433","journal-title":"Br J Cancer"},{"issue":"9","key":"10186_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1242\/dmm.030403","volume":"10","author":"L Gomez-Cuadrado","year":"2017","unstructured":"Gomez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG (2017) Mouse models of metastasis: progress and prospects. Dis Model Mech 10(9):1061\u20131074","journal-title":"Dis Model Mech"},{"key":"10186_CR52","unstructured":"Khanna C, Hunter K, Vlodavsky I (2005) Tail vein assay of cancer metastasis. Curr Protoc Cell Biol. 2001;Chap. 19:19 2 1\u20132 7"},{"issue":"4","key":"10186_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1023\/A:1024062911144","volume":"20","author":"JF Harms","year":"2003","unstructured":"Harms JF, Welch DR (2003) MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis 20(4):327\u2013334","journal-title":"Clin Exp Metastasis"},{"issue":"9","key":"10186_CR54","first-page":"1627","volume":"2","author":"CA Pettaway","year":"1996","unstructured":"Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ et al (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2(9):1627\u20131636","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10186_CR55","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jpedsurg.2007.08.030","volume":"42","author":"RL Meyers","year":"2007","unstructured":"Meyers RL, Katzenstein HM, Krailo M, McGahren ED 3, Malogolowkin MH (2007) Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg 42(12):2050\u20132056","journal-title":"J Pediatr Surg"},{"issue":"12","key":"10186_CR56","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","volume":"2","author":"HS Kuznetsov","year":"2012","unstructured":"Kuznetsov HS, Marsh T, Markens BA, Castano Z, Greene-Colozzi A, Hay SA et al (2012) Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov 2(12):1150\u20131165","journal-title":"Cancer Discov"},{"issue":"29","key":"10186_CR57","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1073\/pnas.0903120106","volume":"106","author":"SY Kang","year":"2009","unstructured":"Kang SY, Halvorsen OJ, Gravdal K, Bhattacharya N, Lee JM, Liu NW et al (2009) Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc Natl Acad Sci U S A 106(29):12115\u201312120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10186_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1086\/411730","volume":"55","author":"IR Hart","year":"1980","unstructured":"Hart IR, Fidler IJ (1980) Cancer invasion and metastasis. Q Rev Biol 55(2):121\u2013142","journal-title":"Q Rev Biol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-022-10186-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T06:10:27Z","timestamp":1668060627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-022-10186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10186"],"URL":"https:\/\/doi.org\/10.1007\/s10585-022-10186-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures and declarations"}},{"value":"The authors declare no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests:"}}]}}